Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 313

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Growth fractions in malignant non‐Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki‐67

Gerdes, Johannes, Dallenbach, Frederike, Lennert, Karl, Lemke, Hilmar, Stein, Harald·1984·Hematological Oncology

Abstract

The proportion of proliferating cells in malignant non‐Hodgkin's lymphomas (NHL) was determined in situ by immunostaining with the monoclonal antibody Ki‐67, which reacts with a nuclear antigen that is present only in proliferating cells. A highly significant correlation could be demonstrated between the proportion of Ki‐67 positive cells and the classification into high and low‐grade NHL according to the Kiel classification. 93·8 per cent of high‐grade and 88·5 per cent of low‐grade malignancies were correctly allocated to these groups using the percentage of Ki‐67 positive cells as discriminant parameter. On the basis of the medians, the degree of proliferation also paralleled the succession of entities within the Kiel classification. Within most of these different entities, however, the ranges of Ki‐67 positive cells varied considerably, indicating that the growth fractions within these groups are rather heterogeneous. Thus it might be useful to determine the growth fraction of each individual case of NHL, because this might be of prognostic value.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hon.2900020406

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 313

Metadata

Authors
Gerdes, J., Dallenbach, F., Lennert, K., Lemke, H., & Stein, H.
Venue
Hematological Oncology
Publisher
Wiley
Published
1984-10
Volume
2
Issue
4
Pages
365-371
ISSN
  • 0278-0232 (ISSN-L)
  • 1099-1069
OpenAlex
W2065002439
Cited by
313
References
15
FWCI
9.17
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Growth fractions in malignant non‐Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki‐67. https://app.cochat.ai/papers/10.1002/hon.2900020406
The paper
Gerdes, J., Dallenbach, F., Lennert, K., Lemke, H., & Stein, H. (1984). Growth fractions in malignant non‐Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki‐67. Hematological Oncology. https://doi.org/10.1002/hon.2900020406

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.